The observations in the early 1990s that airway inflammation associated with asthma leads to an increase in FENO, and that an inhibition of iNOS via inhaled corticosteroids (ICS) treatment acts to lower FENO levels, soon placed exhaled NO as a promising inflammatory marker of asthma [69,73,74]. This evidence concerns the gene NOS2 and asthma.